BioSpace News Archive

BioCapital

FDA alerts health care professionals and patients not to use compounded drugs from Cantrell Drug Company; agency seeks action to stop production and distribution

The agency is concerned about serious deficiencies in Cantrell’s compounding operations, including its processes to ensure quality and sterility assurance that put patient safety at risk.

March 1, 2018
·
4 min read
Business

Apollo Endosurgery, Inc. Reports Fourth Quarter and Full Year 2017 Results

GAAP total revenues of $64.3 million in 2017 compared to $64.7 million in 2016

March 1, 2018
·
13 min read
Business

Tandem Diabetes Care Announces 2017 Financial Results

“The fourth quarter marked the strongest sales in Tandem’s history, with 80 percent growth in our sequential quarterly pump shipments,” said Kim Blickenstaff, President and Chief Executive Officer.

March 1, 2018
·
17 min read
Business

Omeros Corporation Reports Fourth Quarter and Year-End 2017 Financial Results

Total year 2017 OMIDRIA revenues were $64.8 million, a 56.4 percent increase over 2016.

March 1, 2018
·
13 min read
Business

Puma Biotechnology Reports Fourth Quarter and Full Year 2017 Financial Results

The Company reported net revenue from initial sales of NERLYNX of approximately $20.1 million in the fourth quarter and $26.2 million for the full year 2017.

March 1, 2018
·
14 min read
Business

Bristol-Myers Squibb Names José Baselga, M.D., Ph.D. to Board of Directors

Dr. Baselga will serve as a member of Science & Technology Committee of the Board of Directors.

March 1, 2018
·
3 min read
Business

Synergy Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Business Update

TRULANCE® U.S. net sales were $9.4 million in the fourth quarter, totaling $16.8 million for 2017.

March 1, 2018
·
13 min read
Drug Development

IONIS-HTT Rx (RG6042) Top-Line Data Demonstrate Significant Reductions of Disease-Causing Mutant Huntingtin Protein in People with Huntington’s Disease

Ionis Pharmaceuticals, Inc. announced the presentation of positive top-line data from a completed Phase 1/2 study of IONIS-HTTRx (RG6042) in people with early stage Huntington’s disease (HD) at the 13th Annual CHDI HD conference.

March 1, 2018
·
4 min read
Business

Achieve Announces Recent Highlights and Reports Year-End 2017 Financial Results

Achieve Life Sciences, Inc. highlighted recent accomplishments and announced fourth quarter and year-end 2017 financial results.

March 1, 2018
·
3 min read
Job Trends

Magellan Rx Management’s Annual Medical Pharmacy Trend Report Released

Medical benefit drug spending jumps 21 percent in one year.

March 1, 2018
·
5 min read